Edesa Biotech, Inc. Skyrocketed

Edesa Biotech, Inc. (EDSA:NASDAQ) jumped higher at $11.95, representing a gain of 32.8%. The stock appeared on our News Catalysts scanner on Tue, May 19, 2026 at 11:28 AM in the 'BIOTECH' category. From Tue, May 05, 2026, the stock recorded 30.00% Up Days and 27.27% Green Days

About Edesa Biotech, Inc. (EDSA:NASDAQ)

Stellar Biotechnologies Inc is a biotechnology company. The company is engaged in the aquaculture, research, and development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein with an extensive history of safe and effective use in immunological applications. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-targeting agent to create immunotherapies for the treatment of a variety of diseases. It derives its revenues mostly from Europe. Stellar primarily market and distribute products directly to biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers.